We are monitoring the impact of COVID-19 on Latin America Biopharmaceuticals Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 585
Share on
Share on

Latin America Biopharmaceuticals Market Research Report – Segmented By Product Type, By Therapeutic Type & By Country (Brazil, Argentina, Chile, Mexico and Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2019-2024)

Pulished: August, 2019
ID: 585
Pages: 145

LATAM Biopharmaceuticals Market Size & Growth (2019 - 2024)

The size of the Biopharmaceuticals Market in Latin America was worth USD 26.95 billion in 2019 and estimated to be growing at a CAGR of 9.67%, to reach USD 42.75 billion by 2024.

The biopharmaceutical industry has come a long way since the approval of its first drug. Now, several drugs have already been approved and many more are in the last stages of their clinical trial. These drugs have not only innovated the prevention and treatment of the number of life-threatening diseases but have also delivered the thrust for the constant success of the pharmaceutical industry. Several companies are inclining their research to biopharmaceuticals as one drug approved for market selling can represent goldmines for the investors.

A rich late-stage pipeline and growing demand in developing markets are projected to be major drivers in the forecast period. The biopharmaceuticals market is observing substantial growth due to the growing incidence of chronic diseases, rising aging population, technological advancements in biopharmaceuticals, and increasing R&D investments.

Despite the growth of the market, some challenges are faced such as supply chain complexity, lack of developed cold-chain maintenance and stringent approval and production laws.

This research report segmented and sub-segmented into the following categories:

  • By Product Type: Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-stimulating Factor (G-CSF), Interferon And Human Growth Hormones (HGH)
  • By Therapeutic Type: Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular, And Other Therapeutic Areas
  • By Country: Brazil, Argentina, Chile, Mexico and Rest of Latin America

Regionally, Mexico dominates the Latin American market and is expected to lead in the forecast period.

Companies playing a leading role in the LATAM Biopharmaceuticals market are Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services, Pfizer, Inc. and Novartis AG

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Monoclonal Antibodies (mAb)       

                                5.1.2 Erythropoietin       

                                5.1.3 Biotech Vaccines  

                                5.1.4 Recombinant Human (RH) Insulin 

                                5.1.5 Granulocyte colony-stimulating factor (G-CSF)       

                                5.1.6 Interferon               

                                5.1.7 Human growth hormones (HGH)  

                5.2 By Therapeutic Type                               

                                5.2.1 Neurology               

                                5.2.2 Infectious diseases              

                                5.2.3 Diabetes  

                                5.2.4 Oncology 

                                5.2.5 Cardiovascular       

                                5.2.6 Other Therapeutic Areas  

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 Brazil             

                                6.3 Mexico         

                                6.4 Argentina    

                                6.5 Rest of Latin America             

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Merck & Co.                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 F. Hoffmann-La Roche AG                    

                8.3 Eli Lilly and Company                              

                8.4 Sanofi                           

                8.5 Amgen Inc.                 

                8.6 AbbVie Inc.                 

                8.7 Biogen Idec                

                8.8 Bayer AG                     

                8.9 Johnson & Johnson Services                               

                8.10 Pfizer                          

                8.11 Novartis AG                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 


                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Biopharmaceuticals market By Region, From 2019-2024 (USD Billion)
  2. Latin America Biopharmaceuticals market By Product Type, From 2019-2024 (USD Billion)
  3. Latin America Monoclonal Antibodies (mAb) Market By Region, From 2019-2024 (USD Billion)
  4. Latin America Erythropoietin Market By Region, From 2019-2024 (USD Billion)
  5. Latin America Biotech Vaccines Market By Region, From 2019-2024 (USD Billion)
  6. Latin America Recombinant Human (RH) Insulin Market By Region, From 2019-2024 (USD Billion)
  7. Latin America Granulocyte colony-stimulating factor (G-CSF) Market By Region, From 2019-2024 (USD Billion)
  8. Latin America Interferon Market By Region, From 2019-2024 (USD Billion)
  9. Latin America Human growth hormones (HGH) Market By Region, From 2019-2024 (USD Billion)
  10. Latin America Biopharmaceuticals market By Therapeutic Type, From 2019-2024 (USD Billion)
  11. Latin America Neurology Market By Region, From 2019-2024 (USD Billion)
  12. Latin America Infectious diseases Market By Region, From 2019-2024 (USD Billion)
  13. Latin America Diabetes Market By Region, From 2019-2024 (USD Billion)
  14. Latin America Oncology Market By Region, From 2019-2024 (USD Billion)
  15. Latin America Cardiovascular Market By Region, From 2019-2024 (USD Billion)
  16. Latin America Other Therapeutic Areas Market By Region, From 2019-2024 (USD Billion)
  17. Brazil Biopharmaceuticals market By Product Type, From 2019-2024 (USD Billion)
  18. Brazil Biopharmaceuticals market By Therapeutic Type, From 2019-2024 (USD Billion)
  19. Argentina Biopharmaceuticals market By Product Type, From 2019-2024 (USD Billion)
  20. Argentina Biopharmaceuticals market By Therapeutic Type, From 2019-2024 (USD Billion)
  21. Mexico Biopharmaceuticals market By Product Type, From 2019-2024 (USD Billion)
  22. Mexico Biopharmaceuticals market By Therapeutic Type, From 2019-2024 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 2875

Click for Request Sample